Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions

被引:56
|
作者
Sun, Chao [1 ]
Zhang, Han [1 ]
Wang, Xiang [1 ]
Liu, Xinhui [1 ]
机构
[1] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Spine Surg, Nanjing 211100, Peoples R China
来源
FASEB JOURNAL | 2020年 / 34卷 / 08期
基金
中国国家自然科学基金;
关键词
extracellular matrix; fibroblasts; fibrosis; ligamentum flavum; TGF-beta; 1; LUMBAR SPINAL STENOSIS; TISSUE GROWTH-FACTOR; FACET JOINT TISSUE; MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; CONNECTIVE-TISSUE; CANAL STENOSIS; LYSOPHOSPHATIDIC ACID; TGF-BETA; EXTRACELLULAR-MATRIX;
D O I
10.1096/fj.202000635R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertrophy of ligamentum flavum (LF), along with disk protrusion and facet joints degeneration, is associated with the development of lumbar spinal canal stenosis (LSCS). Of note, LF hypertrophy is deemed as an important cause of LSCS. Histologically, fibrosis is proved to be the main pathology of LF hypertrophy. Despite the numerous studies explored the mechanisms of LF fibrosis at the molecular and cellular levels, the exact mechanism remains unknown. It is suggested that pathophysiologic stimuli such as mechanical stress, aging, obesity, and some diseases are the causative factors. Then, many cytokines and growth factors secreted by LF cells and its surrounding tissues play different roles in activating the fibrotic response. Here, we summarize the current status of detailed knowledge available regarding the causative factors, pathology, molecular and cellular mechanisms implicated in LF fibrosis and hypertrophy, also focusing on the possible avenues for anti-fibrotic strategies.
引用
收藏
页码:9854 / 9868
页数:15
相关论文
共 50 条
  • [1] Dysregulation of MicroRNAs in Hypertrophy and Ossification of Ligamentum Flavum: New Advances, Challenges, and Potential Directions
    Zhang, Baoliang
    Chen, Guanghui
    Yang, Xiaoxi
    Fan, Tianqi
    Chen, Xi
    Chen, Zhongqiang
    [J]. FRONTIERS IN GENETICS, 2021, 12
  • [2] Identification and validation of hub genes and pathways associated with mitochondrial dysfunction in hypertrophy of ligamentum flavum
    Gu, Yifei
    Yu, Wenchao
    Qi, Min
    Hu, Jinquan
    Jin, Qianmei
    Wang, Xinwei
    Wang, Chen
    Chen, Yu
    Yuan, Wen
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [3] An in vivo model of ligamentum flavum hypertrophy from early-stage inflammation to fibrosis
    Burt, Kevin G.
    Viola, Dan C.
    Lisiewski, Lauren E.
    Lombardi, Joseph M.
    Amorosa, Louis F.
    Chahine, Nadeen O.
    [J]. JOR SPINE, 2023, 6 (03):
  • [4] Oxidative stress mediates age-related hypertrophy of ligamentum flavum by inducing inflammation, fibrosis, and apoptosis through activating Akt and MAPK pathways
    Chuang, Hao-Chun
    Tsai, Kun-Ling
    Tsai, Kuen-Jer
    Tu, Ting-Yuan
    Shyong, Yan-Jye
    Jou, I-Ming
    Hsu, Che-Chia
    Shih, Shu-Shien
    Liu, Yuan-Fu
    Lin, Cheng-Li
    [J]. AGING-US, 2020, 12 (23): : 24168 - 24183
  • [5] Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1
    Zhang, Kai
    Sun, Wei
    Liu, Xin-yu
    Zhao, Chang-qing
    Li, Hua
    Sun, Xiao-jiang
    Xie You-zhuan
    Ding, Wei
    Zhao, Jie
    [J]. CLINICAL SPINE SURGERY, 2017, 30 (03): : E189 - E191
  • [6] The expression of P16 and S100 associated with elastin degradation and fibrosis of the Ligamentum Flavum hypertrophy
    Wei Hu
    Shunli Kan
    Guang Liu
    Zegang Cao
    Rusen Zhu
    [J]. BMC Musculoskeletal Disorders, 20
  • [7] The expression of P16 and S100 associated with elastin degradation and fibrosis of the Ligamentum Flavum hypertrophy
    Hu, Wei
    Kan, Shunli
    Liu, Guang
    Cao, Zegang
    Zhu, Rusen
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)
  • [8] Cellular and molecular mechanisms of fibrosis
    Wynn, T. A.
    [J]. JOURNAL OF PATHOLOGY, 2008, 214 (02): : 199 - 210
  • [9] Cellular and molecular mechanisms in fibrosis
    Dees, Clara
    Chakraborty, Debomita
    Distler, Joerg H. W.
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 (01) : 121 - 131
  • [10] MOLECULAR AND CELLULAR MECHANISMS OF INDUCTION AND REGRESSION OF CARDIAC FIBROSIS IN VARIOUS MODELS OF MYOCARDIAL HYPERTROPHY
    EGHBALI, M
    [J]. CARDIOVASCULAR PATHOLOGY, 1993, 2 (03) : 199 - 205